Lefamulin最初由Nabriva开发,2018年3月仑胜医药获得在大中华区,包括中国大陆、香港、澳门、台湾开...查看全文
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-11,10% Owner,HBM Healthcare Investments (Ca ,卖出,8597普通股, $11.40
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-10,10% Owner,HBM Healthcare Investments (Ca ,卖出,37876普通股, $10.73
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-07,10% Owner,HBM Healthcare Investments (Ca ,卖出,21501普通股, $10.97
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 内部交易: 2017-04-06,10% Owner,HBM Healthcare Investments (Ca ,卖出,31217普通股, $11.22
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 8-K - Current report Filed: 2017-04-05 AccNo: 0001104659-17-021558 Size: 5 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-03-24 AccNo: 0001104659-17-019162 Size: 12 MB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 8-K - Current report Filed: 2017-03-24 AccNo: 0001104659-17-019161 Size: 172 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 8-K - Current report Filed: 2017-02-15 AccNo: 0001104659-17-009398 Size: 5 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-13 AccNo: 0001615774-17-000561 Size: 52 KB 网页链接
$Nabriva Therapeutics AG - American Depositary Shares(NBRV)$ 8-K - Current report Filed: 2017-02-13 AccNo: 0001104659-17-008630 Size: 31 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements ...